Remote Cardiac Monitoring by the Corsano CardioWatch 287-2 Evaluation Study
- Conditions
- atrial fibrillationhypertensionhigh blood pressure1000752110057166
- Registration Number
- NL-OMON56059
- Lead Sponsor
- Corsano Health B.V.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 190
* >= 18 years old;
* able to provide consent;
* receiving EKG holter or automatic blood pressure cuff for home monitoring per
doctor prescription
* unable to wear the Corsano CardioWatch 287 due to reasons such as allergic
reactions, wounds, amputations etc.;
* unable to receive blood pressure measurements per cuff due to lymphedema,
amputation, dyalisis shunt, wounds, etc.;
* pregnant women;
* breastfeeding women;
* upper arm circumference not within the cuff range (22-42 cm)
* unable or not willing to sign informed consent;
* significant mental or cognitive impairment
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Absolute percentage increase of patients in whom at least one event of atrial<br /><br>fibrillation is detected by the Corsano CardioWatch 287-2 during 28 days of<br /><br>monitoring, compared to a conventional EKG holter during 24-48 hours of<br /><br>monitoring.</p><br>
- Secondary Outcome Measures
Name Time Method <p>(1) Mean blood pressure difference and its SD between blood pressure measured<br /><br>by the Corsano CardioWatch 287-2 and blood pressure measured by a conventional<br /><br>oscillometric blood pressure cuff.<br /><br>(2) Usability of the Corsano CardioWatch 287-2 in a remote care setting as<br /><br>determined by a questionnaire.<br /><br>(3) Difference between awake-asleep blood pressure change as measured by the<br /><br>Corsano CardioWatch 287-2 and awake-asleep blood pressure change as measured by<br /><br>a conventional 30-min. oscillometric blood pressure cuff across 24 hours. </p><br>